Immediate Impact
1 by Nobel laureates 67 standout
Citing Papers
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Cell–cell communication: new insights and clinical implications
2024 Standout
Works of A. Long being referenced
Phase Ib study of olinvacimab (O) with pembrolizumab (P) in patients with recurrent glioblastoma (rGBM).
2020
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| A. Long | 75 | 77 | 30 | 95 | 84 | 29 | 347 | |
| J.F. Sweeney | 58 | 31 | 3 | 17 | 25 | 22 | 384 | |
| John S. Stevenson | 36 | 54 | 2 | 39 | 6 | 46 | 399 | |
| Saira Khan | 1 | 94 | 1 | 96 | 36 | 43 | 310 | |
| Sally A. Smith | 26 | 5 | 77 | 31 | 21 | 389 | ||
| Martina Murphy | 49 | 73 | 71 | 49 | 346 | |||
| Lisa M Force | 38 | 135 | 155 | 16 | 379 | |||
| Ben Byrne | 59 | 130 | 61 | 33 | 407 | |||
| Huifang Zhao | 24 | 42 | 84 | 41 | 375 | |||
| Laura Horne | 60 | 57 | 104 | 22 | 401 | |||
| Rachel Hollis | 27 | 81 | 114 | 24 | 408 |
All Works
Login with ORCID to disown or claim papers
Loading papers...